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Summary 
Mice homozygous for a disruption at the Lyn locus 
display abnormalities associated with the B lympho- 
cyte lineage and in mast cell function. Despite reduced 
numbers of recirculating B lymphocytes, Lyn-‘- mice 
are immunoglobulin M (IgM) hyperglobulinemic. Im- 
mune responses to T-independent and T-dependent 
antigens are affected. Lyn-‘- mice fail to mediate an 
allergic response to IgE cross-linking, indicating that 
activation of LYN plays an indispensable role in FceRl 
signaling. LynP mice have circulating autoreactive an- 
tibodies, and many show severe glomerulonephritis 
caused by the deposition of IgG immune complexes in 
the kidney, a pathology reminiscent of systemic lupus 
erythematosus. Collectively, these results implicate 
LYN as having an indispensable role in immunoglobu- 
lin-mediated signaling, particularly in establishing B 
cell tolerance. 
Introduction 
The SRC family of protein tyrosine kinases have been 
implicated in cell signaling through their physical associa- 
tion with different cell surface receptors that lack intrinsic 
catalytic activity (Bolen et al., 1992). Like several other 
members of the SRC family, LYN is expressed in a broad 
range of cell types and tissues (Bolen et al., 1992). Largely 
through coprecipitation studies, LYN has been shown to 
be physically associated with a number of hematopoietic 
cell surface receptors, including the B cell antigen receptor 
(BCR) (Yamanashi et al., 1991; Burkhardt et al., 1991; 
Campbell and Sefton, 1992), CD40 (Ren et al., 1994), the 
lipopolysaccharide (LPS) receptor (Stefanova et al., 1993), 
the high affinity FcsRl complex (Eiseman and Bolen, 
1992), and the granulocyte colony-stimulating factor 
(G-CSF) receptor (Corey et al., 1994). In most cases, more 
than one member of the SRC family has been found to 
be associated with the same cell surface receptor, raising 
the possibility of functional redundancy within the SRC 
family, a notion supported by the milder than expected 
phenotype associated with mice in which one or other 
SRC-related kinase genes has been disrupted by homolo- 
gous recombination in embryonic stem (ES) cells (re- 
viewed by Varmus and Lowell, 1994). 
A competent, signal-transducing BCR consists of an an- 
tigen-binding membrane immunoglobulin noncovalently 
associated with disulphide-linked heterodimers of immu- 
noglobulin Q and 8/r (Iga and lgf3lr) subunits (Reth, 1992). 
While molecules that make up this BCR complex lack in- 
trinsic catalytic activity, stimulation of resting B cells with 
antibodies to membrane immunoglobulin induces rapid 
tyrosine phosphorylation of B cell proteins, suggesting as- 
sociated tyrosine kinase activities (Gold et al., 1990,199l; 
Campbell and Sefton, 1990). This increase in total cellular 
tyrosine phosphorylation is correlated with an increase 
in the enzymatic activity of several members of the SRC 
family, including LYN, BLK, FYN, and FGR; indeed, coim- 
munoprecipitation studies have shown a physical associa- 
tion between, the BCR complex and several members of 
the SRC family (Yamanashi et al., 1991; Burkhardt et al., 
1991; Campbell and Sefton, 1992; Wechsler and Monroe, 
1995). A highly conserved motif, termed the immunorecep- 
tor tyrosine-based activation motif (ITAM), is found in many 
signal-transducing subunits including the cytoplasmic do- 
main of the Iga and lgplr molecules. Conserved tyrosine 
residues within this ITAM are a target for phosphorylation 
upon ligation of the BCR and presumably provide docking 
sites for additional molecules involved in B cell signaling, 
such as phosphatidylinositol3-kinase, phospholipase Cy2, 
and GTPase-activating protein. Recent studies have shown 
that the cytoplasmic domain of the Iga chain is constitu- 
tively associated with the SRC family kinases LYN and 
FYN (Clark et al., 1992; Pleiman et al., 1994a), suggesting 
that members of the SRC family may directly phosphory- 
late the ITAMs and, thus, participate in very early events 
in the BCR signal transduction cascade. 
Signaling events from the BCR resemble those thus far 
characterized for the FcsRl complex (Ravetch, 1994). 
FcsRl is a tetrameric structure consisting of a ligand- 
bindingasubunit, a8 subunit, and homodimericysubunits 
(Blank et al., 1989). Like the Iga and lgf3lr signaling mole- 
cules of the BCR complex, the cytoplasmic domains of 
the 8 and y subunits of F&RI also contain ITAMs (Ravetch, 
1994). Biochemical studies have shown that LYN is associ- 
ated with the 8 subunit, and it is thought that, on FcsRI 
triggering, LYN becomes activated and phosphorylates 
critical tyrosine residues in the ITAMs of both the 8 and 
y subunits; the phosphorylation of y recruits and activates 
p72”yk, which subsequently activates other molecules in- 
volved in the signal transduction cascade (reviewed by 
Ravetch, 1994). 
To gain an insight into the physiological role of LYN 
and to gauge its importance in relaying signals from these 
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different ceil surface receptors, we have generated Lyn? 
mice by gene targeting in ES ceils. Our results show that 
LYN is an indispensable component of the BCR and FcERI 
complexes and that its actions are required for the elimina- 
tion of autoreactive antibodies. 
Results 
Derivation of Lyn-‘- Mice 
Initial attempts to create Lyn-‘- mice were frustrated by 
the discovery that a significant portion of the coding se- 
quences of the Lyn gene are duplicated (Hibbs et al., 
1995). To overcome this problem, we constructed a tar- 
geting vector designed to replace the Lyn promoter and 
associated regulatory sequences with a PGKNeo expres- 
sion cassette (Figure 1A). Following electroporation of the 
targeting construct into El4 ES cells, a polymerase chain 
reaction (PCR)-based screening assay was employed to 
screen 720 pools. DNA from two pools generated a PCR 
product whose size was predicted following homologous 
recombination of the targeting vector and the Lyn gene. 
On the basis of Southern blot analysis using a probe corre- 
sponding to sequences external to the targeting construct 
as well as aneo probe (data not shown), two clones, desig- 
nated Lyn20.4 and Lyn81 .l , were established. Following 
injection of targeted ES cells into C57BL16 blastocysts, 
chimeras were generated, although only Lyn81.1 cells 
transmitted the disrupted Lyn locus through the germline. 
Lyn*‘- animals were interbred to produce litters that in- 
cluded Lyn-‘- offspring. Southern blot analysis of mouse 
tail DNA from progeny derived from such a mating identi- 
fied the expected three genotypes (Figure 1 B), and these 
were in a ratio consistent with normal patterns of Mende- 
lian inheritance (158 Lyn +I+, 292 Lyre+‘-, 130 Lyn-‘-). Mutant 
mice were viable and fertile, and young mice were superfi- 
cially healthy. 
To verify that the targeted Lyn gene was not expressed, 
reverse transcription-PCR (RT-PCR) analysis using Lyn- 
specific oligonucleotide primers (Hibbs et al., 1995) was 
undertaken with RNA derived from mouse livers. The ex- 
pected 495 bp Lyn-related PCR product was only gener- 
ated using RNA originating from Lyn+‘+ and Lyn+‘- mice 
(data not shown). Moreover, while we were able to detect 
LYN autokinase activity in spleen and liver extracts from 
Lyn+‘+ and Lyn+‘- animals, none was detected in extracts 
prepared from Lyr- animals (Figure 1 C). 
Lyn-‘- Mice Have Reduced Numbers 
of Recirculating B Cells 
The only discernible effect of the Lyn null mutation on 
leukocyte development was observed in the B lymphocyte 
lineage. Changes in the B cell lineage were investigated 
by flow cytometric analyses of lymphoid tissues using 
monoclonal antibodies (MAbs) to the pan-B cell marker 
8220 in combination with an array of MAbs specific for 
developmentally regulated markers. The profiles of LyrP- 
mice and Lyn+‘+ mice were indistinguishable (data not 
shown). The size of the pro-B (B220WZD43+/lgM-), pre-B 
(B220YCD43-/lgM-), and immature B (B220~“/CD4WlgMf) 
cell populations were the same in Lyn+‘+ and Lyr- bone 
marrow. The recirculating B cell (B220VCD43-/lgM+) pop- 
ulation in Lyn-‘- bone marrow, however, was reduced by 
between 50% and 100% compared with controls (Figure 
2). A reduction in the total number of B220+/lgM+ cells 
was also observed in secondary lymphoid tissues from 
the Lyn-‘- mice (Figures 2A and 2B), although again some 
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Figure 1. Generation of Lyn-” Mice 
(A) Targeting vector and homologous recombi- 
nation at the Lyn locus. Shown is a partial re- 
striction map of a portion of the Lyn locus; the 
closed box represents the mouse Lyn pro- 
moter. The targeting vector was constructed 
by replacing approximately 11.5 kb of genomic 
sequence with the PGKNeo expression cas- 
sette. The arrow represents the direction of 
transcription of PGKNeo. A positive control 
construct was generated by ligating an addi- 
tional 840 bp of genomic sequence to the 3’ 
end of the short arm of the targeting construct 
and was used to develop a diagnostic PCR. 
The locations of diagnostic PCR primers 1 and 
2 and the probe used for Southern blot analysis 
are indicated. Wavy lines indicate plasmid se- 
quences. The predicted map of the mutated 
Lyn allele is shown at the bottom. B, BarnHI; 
N, Ncol; H, Hindlll; P, Pstl; X, Xbal. Not all Pstl 
sites are indicated. 
(B) Representative Southern blot analysis of 
progeny from a heterozygote cross. Tail DNA 
was digested with Ncol and probed with the 
diagnostic probe shown in (A). The genotype of each animal is shown above the corresponding lane and is +I+, (wild type), +I- (heterozygote), 
and -I- (homozygous mutant). The size in kilobases is indicated on the left. 
(C) lmmunoprecipitation and kinase assay on liver and spleen extracts of Lyn+‘+, Lyn+‘-, and Lyn-‘- mice. Extracts were immunoprecipitated with 
either preimmune sera (P) or anti-Lyn antisera (I) and subject to kinase assay. Phosphorylated products were separated on 10% polyacrylamide 
gels and revealed by autoradiography. The extracts were not equated for protein concentration. The relative molecular weight in kilodaltons is 
indicated on the left. 
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variation between mice and, somewhat surprisingly, be- 
tween tissues was noted. Mesenteric lymph nodes always 
showed a greater reduction of B cells than the spleen and 
other lymph nodes from the same animal (Figures 2A and 
28). Intriguingly, lymph nodes from the axilla (Figures 2A 
and 28) and groin (data not shown) showed a less pro- 
nounced reduction in B cells, possibly reflecting the extent 
to which the organs are activated. While there was also 
a reduction in B cells in the peripheral blood of Lyn-‘- mice, 
this was not statistically significant (Figures 2A and 28). 
Conventional B cells (B2), but not Ly-1’ B cells (Bi a), were 
markedly reduced in the peritoneal cavity of Lyn? mice 
(Figure 28). The Peyer’s patches in Lyn-‘- mice were con- 
siderably smaller and in some instances undetectable 
macroscopically (data not shown). It is noteworthy that the 
percentage differences in B cells in Lyn-‘- mice reflect 
differences in absolute B cell number, as the average num- 
bers of nucleated cells derived from the organs of Lyn+‘+ 
or Lyn? mice were essentially the same (refer to Figure 
2 legend). 
The reduction in B cell numbers was not due to a selec- 
tive block in B cell development, as the proportion of pe- 
ripheral B cells expressing B cell developmental markers, 
such as major histocompatibility complex class II, surface 
IgD, CD23, heat stable antigen, and MEL14 (data not 
shown), was the same in Lyn- and control mice. 
No significant differences in the T cell composition of 
both primary and secondary lymphoid tissues from Lyn- 
mice were noted (Figure 2B; data not shown); T cell sub- 
sets in the thymus were normal (data not shown). In sec- 
ondary lymphoid tissue, there was a slight increase in the 
proportion of T cells, probably as a direct result of a cor- 
responding decrease in B cells in the same tissue (Fig- 
ure 28). 
6 Cell Function Is Impaired in Lyn-‘- Mice 
The reduction in numbers of recirculating B cells in Lyn-‘- 
mice suggests a defect in their ability to either proliferate 
or persist in the periphery. To distinguish between these 
possibilities, we measured the proliferative potential of B 
cells derived from the axillary lymph node, mesentric 
lymph node, or spleen in a tritium incorporation assay fol- 
lowing stimulation of cultures with either LPS or anti- 
immunoglobulin (Figure 3A). Axillary lymph nodes showed 
little difference between Lyn+‘+ and Lyn? mice in f3 cell 
number, while differences in B cell numbers between 
spleen and mesenteric lymph node were 2-fold and 3-fold, 
respectively (see Figure 28). To compensate for these 
differences, cultures were adjusted to contain equivalent 
numbers of B cells. While lymph node (Figure 3A) and 
splenic B cells (data not shown) from control mice re- 
sponded typically to cross-linking of surface immunoglob- 
ulin with anti-p, the corresponding cells from Lyn-‘- mice 
responded poorly (Figure 3A), and no alteration in the ki- 
netics of the response was evident (data not shown). 
Thesignalingpathwaylinkedtosurfaceimmunoglobulin 
appears to be distinct from that involving LPS activation, 
as anti-p-induced B cell proliferation has been shown to 
Figure 2. Lyn-‘- Mice Have Lower Levels of 
Recirculating B Cells 
(A) Representative two-color fluorescence 
analysis of lymphoid tissues from Lyn+‘+ and 
Lyr- mice stained using MAbs to 8220 and 
IgM. The boxes in the bone marrow profiles 
show the percent of recirculating B cells; the 
percent of B cells present in other tissues are 
indicated. 
(B, left) Proportion of pro-B and pre-B (proB and 
preB), immature B (lmm. B), and recirculating B 
(Rec. B) cells in the marrows of Lyn+‘+ mice 
(closed bars) and Lyn-‘- mice (open bars). Re- 
sults are derived from the analysis of marrows 
from eight mice by two-coior fluorescence us- 
ing MAbs to 8220 and IgM. The average num- 
ber of nucleated cells recovered from Lyn+‘+ 
and Lyn-‘- marrows were 1.95 x 10’ f 0.3 x 
10’ and 2 x 10’ f 0.4 x 107, respectively. 
(B, middle) Proportion of B and T cells in 
lymphoid tissues from Lyn+‘+ m ice (closed bars) 
and Lyn-‘- mice (open bars) enumerated using 
MAbs to 8220 and CD5, respectively. Numbers 
of mice used in the analysis: blood (4) spleen 
(16), axillary lymph node (IO), mesenteric 
lymph node! r6).Theaveragenumberof nucle- 
ated cells recovered from Lyn+‘+ and Lyn-‘- 
mice were as follows: bload, Lyn”’ 8.7 x lo6 f 0.6 x 106, Lyn+ 7 x lo6 f 0.4 x 106; spleen, Lyn+‘+ 1.5 x 108 f 0.3 x 108, Lyn? 1.2 x 
10’ & 0.1 x lOa; axillary lymph node, Lyn +‘+ 10’ f 0.3 x lo’, Lyn-‘- 1.3 x IO’ f 0.45 x 10’; mesenteric lymph node, Lyn+‘+ 2.8 x 107 f 0.4 x 
10’ Lyn-‘- 2.4 x IO7 f 0.8 x 10’. 
(B, right) Proportion of Ly-l+ B cells (Bla), conventional B cells (82) and T cells (T) in the peritoneal cavity of Lyn+‘+ mice (closed bars) and Lyn- 
mice (open bars). Results are derived from the analysis of peritoneal cells from five mice by three-color fluorescence using MAbs to 8220, CD5, 
and IgD. The average number of nucleated cells recovered from Lyn+‘+ and Lyn+ peritoneum were 5.4 x IO6 f 2.2 x lo6 and 7.3 x lo6 f 2.7 x 
1 O6 respectively. 
Asterisks indicate statistical significance, p < 0.001 using Student’s t test. Data are represented as mean 2 SD. 
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Figure 3. B and T Cell Function in Lyn+ Mice 
(A) Mesenteric lymph node cells from Lyn+‘+ (closed bars) or Lyn?‘ 
mice (hatched bars) were cultured for 3 days in the presence of me- 
dium, LPS, or anti-p. DNA synthesis was measured by pulsing with 
[W]thymidine for 6 hr. Representative result of one out of six experi- 
ments is shown. 
(B) Lymph node and spleen cells from Lyn”’ (closed bars) or Lyn? 
mice (hatched bars)were cultured on mitotically inactivated fibroblasts 
expressing CD40 ligand for 3 days. Cultures were pulsed with [3H]thy- 
midine for 6 hr. Representative result of one out of three experiments 
is shown. 
(C) Mesenteric lymph node cells from Lyn+‘+ (closed bars) or Lyn’- 
mice(hatched bars) wereculturedfor3daysin the presenceof medium 
or the T cell mitogen concanavalin A. DNA synthesis was measured 
by pulsing with [3H]thymidine for 6 hr. Representative result of one 
out of three experiments is shown. 
(D) One-way MLR using mitotically inactivated stimulator spleen cells 
from either BALE/c allogeneic mice (allo MLR) or syngeneic mice (auto 
MLR). Responder cells were derived from lymph nodes of Lyn+‘+ 
(closed bars) or Lyn-‘- mice (hatched bars). Data are represented as 
mean f SD. Representative result of one out of two experiments is 
shown. 
require CD45 (Kishihara et al., 1993) and VAV (Tarakhov- 
sky et al., 1995; Zhang et al., 1995) expression, while LPS 
activation is independent of both. To determine the relative 
response to LPS, equivalent numbers of lymph node (Fig- 
ure 3A) and splenic B cells (data not shown) from Lyn+‘+ 
and Lyn-‘- mice were assessed for their ability to respond 
to LPS treatment. While B cells from control animals 
showed a typical response, with a peak at 3 days, B cells 
from Lyn? mice responded poorly(Figure 3A). These data 
indicate that LYN is an important component of the BCR 
complex and plays an indispensable role in normal B cell 
proliferation. 
Interactions between CD40 and its ligand are pivotal in 
T-dependent (TD) B cell antibody responses (Banchereau 
et al., 1994). A recent study has shown that LYN is rapidly 
activated upon cross-linking of CD40 (Ren et al., 1994). 
To address whether B cells from Lyn-‘- mice could respond 
to stimulation through CD40, spleen and axillary lymph 
node cells from Lyn-‘- and control mice were plated on 
mitotically inactivated NIH 3T3 fibroblasts constitutively 
expressing mouse CD40 ligand. No difference was ob- 
served in the proliferative potential of splenic or lymph 
node-derived B cells from control or Lyn-‘- mice, demon- 
strating that LYN is not crucial for signaling a CD40- 
mediated proliferative response (Figure 38). 
Although LYN is not expressed in normal T cells, the 
function of Lyn-‘- T cells was investigated to ensure that 
the aberrant B cell behavior in the Lyn-” mice was not a 
consequence of impaired T cell function. No difference in 
proliferation in the presence of the T cell mitogen conca- 
navalin A was observed in lymph node T cells from Lyn+‘+ 
and Lyn-I- mice (Figure 3C). Moreover, T cells from Lyn+‘+ 
and Lyn-‘- mice, in one-way mixed lymphocyte reactions 
(MLR) using either autologous or allogeneic stimulator 
cells, were indistinguishable in their response (Figure 3D). 
Lyn-‘- Mice Have Elevated Levels of Serum IgM 
The levels of immunoglobulin isotypes in the serum were 
measured by enzyme-linked immunosorbent assay 
(ELISA). Lyn-‘- mice showed normal levels of circulating 
IgGl, IgGPa, IgG2b, and lgG3, but a lo-fold elevation in 
serum IgM (Figure 4A). Lyr? mice had a slightly higher 
level of IgM than Lyn+‘+ mice, but 5-fold less than Lyn-‘- 
mice (Figure 4A). 
An enzyme-linked immunospot (ELISPOT) assay for de- 
tection of antibody-secreting cells was used to determine 
if the elevated level of circulating IgM was due to an in- 
crease in the number of antibody-forming cells (AFCs; Fig- 
ure 48). While no significant differences were observed 
in the number of IgGl-AFCs in Lyn-‘- mice compared with 
control mice, there was a lo-fold increase in the number of 
IgM-AFCs in all Lyn-‘- lymphoid tissues examined (Figure 
4B). Thus, the elevated levels of circulating IgM in Lyn-‘- 
animals is a result of an elevation in the total number of 
IgM-producing plasma cells. 
Perturbed Humoral Immune Responses 
in Lyn-‘- Mice 
Mice challenged with T-independent (TI) antigens secrete 
IgM, followed by a switch to lgG3 (Coffman et al., 1993). 
To determine whether this response was impaired in Lyn-I- 
mice, groups of six Lyn+‘+, Lyn+‘- and Lyn-‘- mice were 
immunized with 10 pg of the habten (Chydroxy3+itro- 
phenyl)acetyl (NP) coupled to the TI carrier LPS (NP-LPS), 
and their serum antibody response was measured weekly 
following immunization. The serum of all mice prior to im- 
munization had measurable levels of NP-binding IgM anti- 
bodies, presumably due to high levels of circulating cross- 
reactive antibody (Figure 5A, i). Although Lyn-‘- mice 
showed no measurable increase in the level of NP-specific 
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Figure 4. Levels of lmmunoglobulin in the Serum of Unchallenged 
Mice and the Frequency of IgGl- and IgM-Secreting Cells 
(A) Levels of immunoglobulin isotypes in the serum of a cohort of six 
Lyn’” (closed bars), Lyn+‘- (open bars), and Lyn? (hatched bars) mice 
as determined by ELISA. Data are represented as the geometric mean 
f SD. 
(6) ELISPOT was used to determine the frequency of IgGl- and IgM- 
AFCs in suspensions of bone marrow, mesenteric lymph node, and 
spleen prepared from two Lyn+‘+ (closed bars) and two Lyn? (hatched 
bars) mice. Data are represented as mean r SD of eight replicate 
wells per sample. Representative result of one out of three experiments 
is shown. 
IgM after immunization with NP-LPS, their ability to re- 
spond to this antigen was evidenced by the appearance 
of NP-specific lgG3 (Figure 5A, i and ii). While Lyn-‘- mice 
mounted an efficient lgG3 response within 1 week of im- 
munization, this response decayed more rapidly than that 
of control mice (Figure 5A, ii). The lgG3 response of Lyn+‘- 
mice also decayed more rapidly than that of Lyn+‘+ mice, 
but was still greater than the response of Lyn-‘- mice. 
These data indicate that Lyn-‘- mice are incapable of sus- 
taining normal antibody responses to TI antigens. 
Challenging mice with TD antigens induces the rapid 
secretion of low affinity IgM antibodies followed byaswitch 
to secretion of IgG and, following somatic mutation, secre- 
tion of higher affinity antibodies (Allen et a!., 1987). To 
determine whether TD responses were impaired in Lyn-‘- 
mice, groups of mice were immunized with 100 pg of NP 
coupled to the protein keyhole limpet hemocyanin (KLH). 
Although both Lyn-‘- and Lyn+‘- mice again had detectable 
levels of circulating cross-reactive IgM antibody prior to 
immunization, the titer increased after immunization in a 
manner analogous to control mice (Figure 58, i). Further- 
more, the three groups of mice produced NP-specific IgGl 
with similar kinetics, and to a similar serum titer (Figure 
5B, ii). 
(i) Titre of Anti-NP IgM Antibody 
Days Post Immunization 
(ii) Titre of Anti-NP lgG3 Antibody 
Days Post Immunization 
B 
(i) Titre of Anti-NP IgM Antibody 
(ii) Titre of Anti-NP IgGl Antibody 
0 10 14 21 
Days Post Immunization 
Figure 5. The Immune Response of Lyn’ Mice after Challenge with 
TI and TD Antigens 
(A) IgM (i) and lgG3 (ii) response of a cohort of Lyn+‘+ (closed bars), 
Lyn+‘- (open bars), and Lyn”- (hatched bars) mice at the indicated 
times after immunization with 10 pg of NP-LPS. 
(B) IgM (i) and IgGl (ii) response of a cohort of Lyn+‘+ (closed bars), 
Lyn+‘- (open bars), and Lyr- (hatched bars) mice at the indicated 
timesafter immunization with 100pgof NP-KLH. Dataare represented 
as geometric mean f SD. 
Histological sections of lymph nodes from Lyn+‘+ mice 
maintained in a conventional animal facility showed the 
presence of numerous germinal centers in B cell follicles 
(Figure 6A). By contrast, lymph nodes from littermate 
Lyn-I- mice show very poorly formed germinal centers, 
suggesting some defect in TD responses (Figure 6B). The 
number of follicle center cells was reduced, the follicles 
lacked zonation, and the mantle zones were poorly devel- 
oped. With progressive aging, there was severe depletion 
of cortical lymphocytes, resulting in small atrophic lymph 
nodes, although plasma cells were still present within the 
medullary cords. Similar progressive changes were seen 
in the B cell zones of the splenic white pulp. 
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Figure 6. Lymph Node Histology, Kidney Pa- 
thology, and Autoantibodies in Control and 
Lyr- Mice 
(A) Low power view of a lymph node from a 
control mouse showing well-formed secondary 
follicles with germinal centers (arrow). 
(B) Low power view of a lymph node from a 
Lyn- mouse showing poorly formed follicles 
(indicated by arrows). 
(C) High power view of the renal cortex from a 
control mouse showing a normal glomerulus. 
(D) High power view of the renal cortex from a 
Lyn- mouse showing an abnormal glomerulus 
with hypercellularity, lobularity, and segmental 
sclerosis. 
(E) High power view of the renal cortex from a 
Lyn? mouse showing severely damaged glo- 
meruli with global sclerosis and crescent for- 
mation. 
(F) High power view of PAS-M-stained section 
through the renal cortex of a control mouse 
showing normal single contour of peripheral 
capillary loop basement membrane. 
(G) High power view of PAS-M-stained section 
through the renal cortex of a Lyn+ mouse indi- 
cating mesangial interposition seen as tram- 
tracking or double contours of the peripheral 
capillary loop (arrows). 
(H) View of the renal cortex from a control 
mouse stained with a pool of goat anti-mouse 
IgGs indicating a lack of immune complexes 
(magnification, 200x). 
(I) View of the renal cortex from a Lyn? mouse 
showing IgG-containing immune complexes in 
glomeruli (magnification, 200x). 
(J-M) lmmunofluorescent analysis of human 
HEp-2 cellsstained with antisera from acontrol 
mouse(J) differentLyn-mice(K-M)(mag- 
nification 200 x). 
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IgE-Mediated Anaphylaxis Is Defective 
in Lyn-‘- Mice 
Since LYN has been shown to be associated with the FcsRl 
complex and since IgE-mediated anaphylaxis is depen- 
dent on FcsRl triggering of mast cells, we sought to deter- 
mine whether FccRl triggering is compromised in Lyn- 
mice in a passive cutaneous anaphylaxis (PCA) model 
(Wershil et al., 1987). While control mice mounted a rapid 
PCA reaction, which is readily visualized by Evans blue 
extravasation due to an increase in vascular permeability 
as a result of mast cell degranulation, Lyn-l- mice failed to 
mediate this anaphylactic response (Figure 7). The defect 
reflected an impairment in mast cell function rather than 
simply a reduction in mast cell numbers, as no differences 
in the numbers of mast cells in the ears of Lyn+‘+ and Lyn-I- 
mice was noted (data not shown). 
Lyn-‘- Mice Develop Severe Glomerulonephritis as 
a Result of IgG Immune Complex Deposition 
in the Kidney 
With increasing age, we noticed a significant decline in 
the numbers of Lyn-‘- mice compared with control mice. 
Unlike control mice that remained healthy, a proportion 
of Lyn-‘- mice aged from 4 weeks to 10 months became 
emaciated and were sacrificed. Analysisof their peripheral 
blood showed that all animals were severely anemic, and 
several were also leukopenic and thrombocytopenic (data 
not shown). Analysis of the bone marrows of these mice 
indicated that the pancytopenia was most likely due to 
peripheral destruction of hematopoietic cells and not to 
primary marrow failure (data not shown). Extramedullary 
hematopoiesis was notably increased within splenic tissue 
after 16 weeks of age. 
Histological examination of solid organs revealed se- 
vere renal disease (Figure 6). Glomerular damage con- 
sisting of hypercellularity, lobularity, and focal sclerosis 
was apparent (Figure 6D). In some instances, glomeruli 
Figure 7. Passive Cutaneous Anaphylaxis in Control and Lyn- Mice 
Lyn+‘+(leftof figure)andLyn- mice (right of figure) weregiven intrader- 
mal injections in their left ears with 20 ng of mouse anti-DNP IgE 
diluted in PBS and in their right ears with PBS. After 24 hr, mice were 
injected intravenously with DNP-HSA in Evans blue. The typical PCA 
reaction, as indicated by extravasation of Evans blue dye, is seen in 
the left ear of the Lyn+‘+ mouse but is not evident in the corresponding 
ear of the Lyn? mouse. 
were globally sclerotic; glomerular crescents were occa- 
sionally seen (Figure 6E). In addition, mesangial interposi- 
tion was present in the peripheral capillary loops (Figure 
6G). Occasional animals also showed necrotic glomerular 
lesions, consistent with a microcapillary vasculitis. These 
severe glomerulonephritic changes correlate clinically 
with renal failure, a probable cause for the demise of some 
Lyn-‘- animals. Analysis of the kidneys from apparently 
healthy Lyn’ mice of 6 weeks of age showed variable, 
but less severe glomerular damage, indicating early onset 
of the renal disease (data not shown). 
The possibility that the glomerulonephritic process was 
secondary to immune dysfunction was investigated. Im- 
munochemical staining of frozen sections of kidney using 
isotype-specific antibodies showed deposition of IgG im- 
mune complexes in the glomeruli (Figure 61). This immune 
complex deposition was evident in mice at an early age 
(data not shown). The presence of immune complexes 
was confirmed by electron microscopy, since subendo- 
thelial and mesangial electron dense deposits were identi- 
fied (data not shown). Immune complex glomerulonephri- 
tis isonlyseen when the precipitating antigen is persistent, 
as in chronic infections or autoimmune disease. The pres- 
ence of autoreactive antibodies was investigated by test- 
ing the capacity of sera from glomerulonephritic Lyn- and 
control mice to react with autoantigens. While no staining 
was seen using serum from control mice (Figure 6J), auto- 
antibodies were evident in serum from glomerulonephritic 
Lyn-‘- mice (Figures 6K-6M). While most sera reacted with 
nuclear and cytoplasmic antigens (Figures 6K and 6L), 
some reacted predominantlywith nuclear antigens (Figure 
6M). Collectively, these data indicate that the glomerulo- 
nephritis seen in Lyn-I- mice is due to the deposition of 
IgG immune complexes containing autoreactive anti- 
bodies. 
A survival study has shown that by 25 weeks of age, 
42% of Lyn-‘- mice had either succumbed or were devel- 
oping signs of autoimmune disease, as evidenced by the 
presence of blood in their urine. Moreover, >90% of mice 
of more than 6 weeks of age showed histological signs of 
autoimmune disease. 
Discussion 
Our studies of Lyn-‘- mice have revealed that LYN has an 
indispensable role in BCR-mediated signal transduction 
that is required for T cell-independent B cell proliferation 
and in triggering the elimination of autoreactive B cells. 
All Lyn-‘- mice have reduced numbers of B cells, al- 
though different lymphoid tissues from the same mouse 
show considerable variation. The peritoneal cavity, mes- 
enteric lymph nodes, and Peyer’s patches, which perhaps 
resemble the most active lymphoid compartments, show 
the greatest depletion in B cells. A reduction in bone mar- 
row output might explain the peripheral B cell deficit; how- 
ever, there is no evidence to suggest any alterations in B 
cell developmental compartments in Lyn- marrows. 
While it is also feasible that the longevity of peripheral B 
cells may be reduced, the more probable explanation for 
the reduction in B cell numbers in Lyn-‘- mice is a failure 
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of 6 cells to expand in the periphery. This explanation is 
consistent with our in vitro studies for B cell proliferation 
and is implied from both the histological examination of 
lymph nodes, which show a failure to form normal germinal 
centers, and the reduced duration of the TI response in 
Lyr- mice. 
Germinal centers develop in B cell follicles of secondary 
lymphoid tissues during TD antibody responses and are 
associated with clonal B cell expansion, somatic mutation 
of immunoglobulin variable region genes, and selection 
of higher affinity antibodies, as well as the generation of 
plasma cells and memory B cells (MacLennan, 1994). 
Thus, the apparent failure of Lyn-‘- mice to develop normal 
germinal centers suggests that there may be defects in 
some aspects of TD responses such as the ability to gener- 
ate high affinity antibodies or memory B cells. This phe- 
nomenon, however, may depend on antigen concentra- 
tion, since in preliminary experiments Lyn-I- mice showed 
an impairment in their primary TD response only at low 
doses of antigen (data not shown). The absence of normal 
germinal centers and elevated levels of serum IgM found 
in Lyn? mice is also seen in humans carrying a mutation 
in the gene encoding CD40 ligand (Aruffo et al., 1993). 
That the absence of normal germinal centers in Lyn-‘- mice 
is not due to a defect in CD40 signaling is indicated by 
two observations. First, Lyn-‘- mice have normal IgG se- 
rum titers and generate IgGl antibodies in response to a 
TD antigen, whereas the CD40 ligand mutation results in 
agammaglobulinemia (Aruffo et al., 1993). Second, Lyn-‘- 
B cells proliferate normally when stimulated through CD40. 
B cell abnormalities associated with Lyn-l- mice resem- 
ble those seen in mice carrying either naturally occurring 
or engineered mutations in other genes. The xid mouse 
is characterized by a mutation in BTK (Thomas et al., 1993; 
Rawlings et al., 1993). As in Lyn-I- mice, xid mice have 
reduced numbers of peripheral B cells and show poor pro- 
liferation in response to stimulation with anti-immuno- 
globulin and possibly also LPS (Belmont, 1995). Addition- 
ally, TD antibody responses in xid mice are essentially 
normal, and TI responses are severely impaired (Belmont, 
1995). The two phenotypes, however, are not identical; B 
cell deficiency in xid mice is due to a maturational block, 
and xid mice show reduced levels of serum IgM. Despite 
these differences, the similarity between the Lyn? and 
xid phenotypes is intriguing, and it is tempting to speculate 
that BTK and LYN participate in the same signal transduc- 
tion pathways. 
It is noteworthy that O&2-‘- mice, like Lyn-‘- mice, have 
reduced numbers of recirculating B cells, and in addition, 
Ott-2-‘- B cells fail to respond to TI mitogens but proliferate 
and differentiate normally in response to T cell signals in 
vitro (Corcoran et al., 1993; Corcoran and Karvelas, 1994). 
Immune responses toTI antigens in mice repopulated with 
Ott-2-‘- cells are also depressed. Ott-2, however, does 
not regulate Lyn gene transcription, as normal levels of 
Lyn message are present in O&-2-‘- B cells (Corcoran 
and Karvelas, 1994). Finally, the phenotype of Vat+ mice 
shows a number of similarities to Lyn-‘- mice. Vav-‘- mice 
show diminished B cell responses to anti-immunoglobulin, 
although they respond normally to LPS (Tarakhovsky et 
al., 1995; Zhang et al., 1995) and may have reduced num- 
bers of peripheral B cells (Tarakhovsky et al., 1995; Fi- 
scher et al., 1995). TD responses of Vat? mice also ap- 
pear to be normal (Tarakhovsky et al., 1995; Zhang et al., 
1995). The similarity of the B cell phenotype of mice with 
mutations in different signal transduction molecules is 
consistent with the cascade of interactions believed to OC- 
cur following ligation of the BCR (Pleiman et al., 1994b). 
Two aspects of the phenotype of Lyn-‘- mice are particu- 
larly intriguing: the elevated levels of both IgM antibody 
and IgM-secreting cells and the existence of circulating 
autoantibodies. While examples of hyper-IgM with an as- 
sociated autoimmunity have been described in other 
strains of mice, the nature of these conditions appears to 
be distinct from that found in Lyn-‘- mice. In NZB and 
related strains, the hyper-IgM and autoantibody produc- 
tion are associated with a B cell hyperplasia, particularly 
of the Ly-1 B cell subset (Hayakawa et al., 1983). Similarly, 
viable motheaten mice, which are affected by a severe 
autoimmune condition early in life, contain only Ly-1 B 
cells (Sidman et al., 1986). In contrast, the Ly-1 B cell 
subset is unchanged in Lyn-‘- mice. This suggests that 
the autoimmunity in Lyn-‘- mice is not a consequence of 
changing the cellular composition of the B cell population, 
but rather results from altering signal transduction within 
each B cell. In this scheme, the differentiation of Lyn-‘- B 
cells into antibody-secreting cells results from aberrant 
processing of an immunoglobulin-mediated signal. It is 
possible that, upon encountering self-antigens, Lyn-‘- B 
cells are neither deleted nor do they remain ignorant, but 
rather differentiate into plasma cells. While self-reactive 
IgM antibodies are usually considered relatively benign, 
they could assume pathological significance at high con- 
centration. The immune complexes generated could act 
as a focal point for T cell recruitment and the consequent 
development of a more pathological IgG-mediated condi- 
tion. The glomerulonephritis and pancytopenia seen in 
these mice bear many similarities to the renal and hemato- 
logical pathology manifest in systemic lupus erythemato- 
sus (SLE), a disease characterized by the production of 
multiple autoantibodies and immune complex deposition. 
In SLE, genetic susceptibility combined with an environ- 
mental trigger is thought to cause autoantibody production 
by B cells, at least in part due to abnormal B cell signaling 
(Mountz et al., 1991; Drake and Kotzin, 1992). Perhaps 
the normal function of LYN is critical for the maintenance 
of self-tolerance in the face of adverse environmental 
triggers. 
In addition to the importance of LYN in B cell signaling, 
our studies have also pointed to a critical role for LYN in 
mast cell function. The importance of FcsRl in the allergic 
response has previously been demonstrated in mice lack- 
ing this receptor by disruption of either a or y subunits 
(Dombrowicz et al., 1993; Takai et al., 1994). We have 
shown that mice deficient in a signal transduction mole- 
cule, LYN, are defective in mediating cutaneous anaphy- 
laxis and thus directly implicate LYN as a crucial signaling 
component of this receptor complex. 
B cells can respond in a number of different ways to 
stimulation with antigen, and their response is dependent 
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on their state of differentiation and on the concentration of 
antigen. They can be induced to proliferate, to differentiate 
into antibody producing cells or memory cells, and under 
certain conditions, they can be either clonally deleted or 
made unresponsive. Our data suggests that LYN is not 
only necessary for 6 cell proliferation but also for clonal 
deletion of autoreactive B cells. Future studies will be 
aimed at investigating the role of LYN in establishing B 
cell tolerance. 
Experimental Procedures 
Generation of Lyn-‘- Mice 
Genomic clones containing the mouse Lyn promoter were used to 
construct the targeting vector and have been described previously 
(Hibbs et al., 1995). The PGKNeo expression cassette (Tybulewicz et 
al., 1991) was inserted in reverse transcriptional orientation to the Lyn 
gene between a Pstl site upstream of the promoter and an Xbal site 
approximately 11.5 kb downstream in intron 1, creating a construct 
with a long arm of homology of 5.3 kb and a short arm of 1 .l kb in 
length. 
El4 ES cells (Handyside et al., 1989) were propagated and electro- 
porated as described (Mann et al., 1993). Selection for growth in G418 
was initiated 24 hr after electroporation, and G418-resistant colonies 
were micromanipulated after a further 7 days. We replated 20% of 
the cells comprising an individual colony into a well of a 96-well plate 
containing mitotically inactivated ST0 cells and used these as a stock: 
the remaining 80% of cells were replated and cultured for a further 
4 days, after which DNA was prepared from pools of two or four clones. 
PCR reactions were carried out using 1 ~1 of the DNA sample in the 
presence of 2.0 mM MgCl* using Tth plus DNA polymerase (Biotec 
International, Bentley, Western Australia). PCR products were gener- 
ated by 35 cycles at 95°C (30 s), 60°C (30 s), and 72OC (90 s). Of 
the primers used to identify homologous recombinants, primer 1 was 
complementary to sequences at the 5’ end of the PGK promoter 
(S-dTGCTACTTCCATTTGTCACGTCC-37, and primer 2 was comple- 
mentary to Lyn genomic sequences downstream of the short arm of 
homology (5’-dACAGAGCTAGACCGTTCTlTCCTC-3’) (Figure 1A). A 
third primer was used in combination with primer 2 to identify the 
wild-type Lyn allele (5’-dCAGGTGGAGCATACCTGGCTGTTT-3’). 
Two targeted ES cell clones identified by PCR, and verified by 
Southern blot analysis, were injected into blastocysts of C57BU6 mice 
and transplanted into the uteri of psuedopregnant females. Chimeric 
animals were mated with C57BU6 mice, and germline transmission 
of the mutated Lyn allele was identifed by Southern blot analysis of 
Ncol-digested genomic DNA using probes to Lyfrgenomic sequences 
outside of the targeting vector (Figure 1A) and to the neorgene. Mice 
were maintained in a conventional animal facility. 
lmmunoprecipitation and Kinase Assays 
Spleen and liver extracts were prepared, immunoprecipitated with pre- 
immune or LYN-specific antisera, and subject to kinase assay as de- 
scribed (Stanley et al., 1991). 
Flow Cytometric Analysis 
Bone marrow Cells were obtained by flushing femurs, and peritoneal 
cavity cells were isolated by peritoneal lavage using PBS, 1% FBS. 
Peripheral blood (0.2 ml) was depleted of red blood cells using 0.83% 
NH&I prior to staining. Single cell suspensions were prepared from 
lymphoid organs in PBS, 1% FBS. Cells (105) were incubated with 
FITC- and PE-conjugated MAbs and analyzed using a FACScan (Bec- 
ton-Dickinson, San Jose, CA). For three-color analysis, a biotinylated 
antibody revealed with Tricolor Avidin (Caltag, South San Francisco, 
CA) was used in addition to direct FITC and PE conjugates. Dead cells 
were excluded on the basis of propidium iodide uptake, and 10,000 
events were acquired. The following MAbs were used: RA3-6B2 
(B220), 331.12 (IgM), goat anti-mouse IgD (Nordic Immunological Lab- 
oratories, Tilburg, The Netherlands), 187.1 (Igr), JC5 (Igh), S7 (CD43), 
8384 (CD23), Ml 169 (HSA), MU1 14 (la”,“), GK1.5 (CD4), 53.6 (CDE), 
53.7 (CD5), Ml170 (CD1 1 b), 6B2-EC5 (GR-l), and MEL14 (L-selectin). 
Proliferation Assays 
Cells were cultured at a density of 5 x lo5 B cells/ml in complete 
RPMI. Anti-immunoglobulin stimulation was performed using a F(ab’), 
goat anti-mouse IgM (Capella, Durham, NC) at a final concentration 
of 25 pg/ml. LPS (Difco, Detroit, Ml) was used at a final concentration 
of 20 Kg/ml. CD40 ligand-transfected 3T3 fibroblasts were generated 
using standard techniques and were irradiated at 3000 rad. Tritiated 
thymidine (10 ICi) was added to the cultures on the indicated days, 
and the cells were harvested 6 hr later. DNA was immobilized onto 
filters, and the amount of thymidine incorporated was determined using 
a scintillation counter (Packard Instrument Company, Meriden, CT). 
Immunization, ELISA, and ELISPOT Assays 
NP-KLH (100 fig in alum) and NP-LPS (IO Kg in PBS), prepared as 
described (Lalor et al., 1992), were administered by intraperitoneal 
injection. Serum titers of antigen-specific immunoglobulin of the indi- 
cated isotypes were determined at regular intervals after immunization 
using an NP-specific ELISA performed as described (Smith et al., 
1994). Total serum immunoglobulin titers were determined by ELISA, 
using sheep anti-mouse immunoglobulin (Silenus Laboratories, Haw- 
thorn, Australia) as a capture reagent, and developed with isotype- 
specific goat sera directly conjugated with horseradish peroxidase 
(Southern Biotechnology Associates Incorporated, Birmingham, AL). 
Purified myeloma proteins (Sigma Chemical Company, St. Louis, MO) 
were used as standards. ELISPOT assays were carried out as de- 
scribed(Laloret al., 1992), again usingsheepanti-mouse immunoglob- 
ulin (Silenus) capture and goat anti-mouse immunoglobulin (Southern 
Biothechnology Associates Incorporated) developing reagents. 
lmmunohistochemistry and lmmunofluorescence 
Anti-nuclear antibodies were detected using fixed human HEp-2 cells 
(Immuno-Concepts, Sacramento, CA), following the instructions of the 
manufacturer, Sera from Lyn”+and Lyr- mice were used at a dilution 
of 1: 100 and 1 :I 000, respectively. Bound antibodies were revealed 
with a fluoresceinated sheep anti-mouse immunoglobulin serum (Sile- 
nus Laboratories). Frozen sections of kidneys were prepared and 
stained as described (Smith et al., 1994). Immune complexes were 
detected by staining with a pool of IgGi-, IgGZa-, and IgG2b-specific 
sera directly conjugated to horseradish peroxidase (Southern Biotech- 
nology Associates Incorporated). 
Histology 
Tissues were fixed for light microscopy in either formalin or Bouin’s 
solution for 24 hr and embedded in paraffin. Sections were stained 
with hematoxylin and eosin, periodic acid silver methananine (PAS-M), 
or alcian blue according to standard procedures. Sections for electron 
microscopy were prepared following fixation in 2.5% glutaraldehyde, 
postfixing in osmium tetroxide, embedding in Spurr’s resin, and stain- 
ing with lead citrate. 
Passive Cutaneous Anaphylaxis 
Control and Lyr- mice were anaesthetized with chloral hydrate and 
then given intradermal injections of 20 ng of mouse anti-DNP IgE 
antibody (Sigma) diluted in 20 ~1 of PBS in their left ears. The right 
ears of the same mice were injected with PBS. After 24 hr, the mice 
were given an intravenous injection of 100 pg of DNP-HSA (Sigma) 
in 100 ~1 of 0.9% NaCI, 1% Evans blue dye. The PCA reaction was 
evident within 5 min of the second injection, and after 60 min, mice 
were culled and their ears subject to histological analyses. 
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